Journal
JOURNAL OF CELL SCIENCE
Volume 132, Issue 16, Pages -Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.230748
Keywords
Oncogene-induced senescence; B-RAF-V600E; EGR1; Glucocorticoid; CDKN1A; CDKN2B
Categories
Funding
- Fondation ARC pour la Recherche sur le Cancer
- Fondation pour la Recherche Medicale
- GEFLUC Paris Ile-DeFrance
- Ligue Contre le Cancer (Comite Val d'Oise)
Ask authors/readers for more resources
Expression of hyperactive RAF kinases, such as the oncogenic B-RAF-V600E mutant, in normal human cells triggers a proliferative arrest that blocks tumor formation. We discovered that glucocorticoids delayed the entry into senescence induced by B-RAF-V600E in human fibroblasts, and allowed senescence bypass when the cells were regularly passaged, but that they did not allow proliferation of cells that were already senescent. Transcriptome and siRNA analyses revealed that the EGR1 gene is one target of glucocorticoid action. Transcription of the EGR1 gene is activated by the RAF-MEK-ERK MAPK pathway and acts as a sensor of hypermitogenic pathway activity. The EGR1 transcription factor regulates the expression of p15 and p21 (encoded by CDKN2B and CDKN1A, respectively) that are redundantly required for the proliferative arrest of BJ fibroblasts upon expression of B-RAF-V600E. Our results highlight the need to evaluate the action of glucocorticoid on cancer progression in melanoma, thyroid and colon carcinoma in which B-RAF-V600E is a frequent oncogene, and cancers in which evasion from senescence has been shown.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available